~~<i id='ACD4AE0B7F'><strike id='ACD4AE0B7F'><tt id='ACD4AE0B7F'><pre id='ACD4AE0B7F'></pre></tt></strike></i>~~

Home» comprehensive» comprehensive

comprehensive

author：comprehensive 2025-09-27 07:40:10 Page View：92862

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Weight bias in eating disorder treatment complicated by new weight loss drugs
Next article： Continuity nursing helped my family in our darkest PICU moments

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

NIH director takes cautious approach to Biden drug pricing priority

NIHDirectorMonicaBertagnolliKevinDietsch/GettyImagesWASHINGTON—PresidentBidenhaspromisedtorequirefai

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

#NeedHerScience: shining a light on gender disparities in medicine

AdobeMedicinehasanabundanceofhighlytrainedandqualifiedwomen.Sowhyaretheresofewofthematthehighestleve